As of 2025-11-09, the Relative Valuation of 10X Genomics Inc (TXG) is (20.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of 10X Genomics Inc based on Relative Valuation is -234.8%.
The range of the Relative Valuation is (18.99) - (18.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.9x - 33.3x | 32.9x |
| Forward P/E multiples | 27.6x - 27.9x | 27.6x |
| Fair Price | (18.99) - (18.97) | (20.56) |
| Upside | -224.5% - -224.4% | -234.8% |
| Date | P/E |
| 2025-11-07 | -22.44 |
| 2025-11-06 | -19.13 |
| 2025-11-05 | -19.85 |
| 2025-11-04 | -19.66 |
| 2025-11-03 | -20.16 |
| 2025-10-31 | -20.07 |
| 2025-10-30 | -18.31 |
| 2025-10-29 | -18.98 |
| 2025-10-28 | -19.63 |
| 2025-10-27 | -20.00 |
| 2025-10-24 | -20.26 |
| 2025-10-23 | -19.66 |
| 2025-10-22 | -18.04 |
| 2025-10-21 | -19.17 |
| 2025-10-20 | -19.34 |
| 2025-10-17 | -17.41 |
| 2025-10-16 | -18.22 |
| 2025-10-15 | -17.50 |
| 2025-10-14 | -16.98 |
| 2025-10-13 | -17.07 |
| 2025-10-10 | -16.88 |
| 2025-10-09 | -17.23 |
| 2025-10-08 | -17.76 |
| 2025-10-07 | -17.07 |
| 2025-10-06 | -18.60 |
| 2025-10-03 | -18.76 |
| 2025-10-02 | -18.11 |
| 2025-10-01 | -18.23 |
| 2025-09-30 | -17.20 |
| 2025-09-29 | -16.69 |
| 2025-09-26 | -17.25 |
| 2025-09-25 | -17.58 |
| 2025-09-24 | -17.75 |
| 2025-09-23 | -18.38 |
| 2025-09-22 | -19.19 |
| 2025-09-19 | -19.19 |
| 2025-09-18 | -19.53 |
| 2025-09-17 | -18.92 |
| 2025-09-16 | -19.32 |
| 2025-09-15 | -19.64 |
| 2025-09-12 | -18.60 |
| 2025-09-11 | -19.22 |
| 2025-09-10 | -18.53 |
| 2025-09-09 | -19.87 |
| 2025-09-08 | -20.50 |
| 2025-09-05 | -20.54 |
| 2025-09-04 | -19.97 |
| 2025-09-03 | -19.63 |
| 2025-09-02 | -19.67 |
| 2025-08-29 | -20.62 |